Cardio Catch-Up: Gel For Fixing Heart Attacks, ‘Uncaged’ Coronary Stents, And More
Executive Summary
Medtech Insight’s Cardiovascular Catch-Up highlights recent news on cardiovascular tech innovations in the last two months. Part II of this month’s update includes innovative research and development news from smaller companies and research labs that you may have missed.
You may also be interested in...
Biosensors International Wins FDA Approval For Drug-Eluting Coronary Stent
The US agency’s Center for Devices and Radiological Health has granted a PMA to Biosensors International USA for its BioFreedom drug-eluting coronary stent System to treat coronary artery disease.
Start-Up Spotlight: Elixir Works To 'Uncage' The Coronary After Intervention
The company is sponsoring INFINITY SWEDEHEART, a randomized trial of its DynamX Bioadaptor, a unique metallic coronary artery implant that adapts to vessel physiology.
MedAlliance Secures $50M To Aid Trials And Commercialization
Trustar Capital’s investment will allow MedAlliance to pursue commercialization of its drug eluting balloon and further its trial efforts.